IL6 and esophageal squamous cell carcinoma: In conclusion, our study shows the consistent IL6 overexpression in ESCC cells, suggesting its potential use as a therapeutic target for ESCC, and the paracrine induction of the expression of the antiapoptotic gene BCL3, revealing alterations that may contribute to ESCC development.